No phaseRecruiting
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension (MOMENTOUS)
- Sponsor
- Tempus AI (Industry)
- Enrolment
- 900 planned
- Conditions
- Pulmonary Hypertension; Interstitial Lung Disease (ILD)
- Interventions
- ECG-based AI Device - Results Returned to Investigator; Echocardiogram and Right Heart Catheterization; ECG-based AI Device - Results Not Returned to Investigator
- Ages
- adults, older adults
- Registry
- NCT06911632
Full record on ClinicalTrials.gov
From the registry
MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.
Primary outcomes
- Proportion of participants receiving a new diagnosis of PH within the High risk Device group compared to the High risk Control group.
History
Study completion expected
Primary completion expected
Last registry update
Started
Registered